The Mayo Clinic of Regenerative Medicine
BioXcellerator
A vertically integrated platform uniting GCP-compliant clinical services, in-house biotech manufacturing, and a growing intellectual property portfolio under one corporate structure. A decade of operations. 50,000+ stem cell applications. 170+ conditions treated. A platform built for institutional scale.
A Decade of Operational Proof
As Seen In
BioXcellerator's clinical results, innovation platform, and investment story have attracted coverage from leading media, sports, and entertainment outlets.
Sports Illustrated
Entrepreneur Magazine
Men's Health
Maxim Magazine
LifeSciences Magazine
A Broken Industry. A Built Solution.
Regenerative medicine is one of the fastest-growing sectors in global healthcare — and one of the most fragmented. BioXcellerator was built to solve that.
The Problem
Regenerative medicine is entering a major growth phase — yet most providers are fragmented, lightly controlled, and poorly standardized.
Patients face confusion and inconsistency: variable cell quality, no chain of custody, and limited clinical oversight across the sector.
Investors face a market where most companies lack the operational infrastructure, quality systems, or IP to become category leaders.
Without vertical integration, providers are perpetually dependent on third-party cell suppliers — with no control over quality, cost, or differentiation.
The BioXcellerator Solution
BioXcellerator built the integrated platform needed to become the standard-setting company in regenerative medicine — the Mayo Clinic of the sector.
One coordinated platform combining healthcare services, GCP-compliant clinical delivery, in-house manufacturing, research, and product development.
Multiple ISO certifications across both the clinical and technology divisions — with Good Clinical Practices, chain of custody, and documented outcomes at every level.
A proprietary IP portfolio, peer-reviewed science, and a Health Advisory Board that gives BioXcellerator the credibility infrastructure no competitor can replicate quickly.
"The Mayo Clinic of Regenerative Medicine"
One Platform. Vertically Integrated. A Defensible Moat.
Most regenerative medicine companies are either clinics or manufacturers. BioXcellerator is both — and more. Our vertical integration model controls the entire value chain: from cell sourcing and in-house manufacturing to GCP-compliant clinical delivery and IP commercialization.
This structure creates compounding competitive advantages: lower cost of goods, proprietary products, clinical data generation, and multiple revenue streams — all within a single corporate entity operating under multiple ISO certifications and Good Clinical Practices.
This is what it means to be the Mayo Clinic of regenerative medicine — not just a clinic, but a platform with the quality infrastructure, scientific depth, and operational control to define the category.
BioX Companies
Flagship brand: BioXcellerator
BioX Companies is the healthcare services operating company, with BioXcellerator as its flagship clinical brand. Together with BioX Innovations Vault, the platform operates as a vertically integrated enterprise — unified by shared quality systems, GCP standards, and a common IP portfolio.
BioX Companies
The healthcare services operating company. BioXcellerator is the flagship clinical brand — a GCP-compliant regenerative medicine clinic in Medellín, Colombia delivering 50,000+ stem cell applications across 170+ conditions.
BioX Innovations Vault
In-house cell therapy manufacturing under multiple ISO certifications, proprietary product formulations, and an expanding IP portfolio including Quantum MU53, EVOKE Exosomes, BioX Gel, and Skincare.
BioX Global
Licensing, distribution, and clinical partnership development across Latin America, Europe, and the Middle East — extending the BioXcellerator standard of care globally.
Investment Highlights
The competitive advantages that make BioXcellerator the Mayo Clinic of regenerative medicine — and a category-defining investment.
Vertical Integration
The only company in the sector that controls clinical delivery, cell manufacturing, and IP under one corporate structure — eliminating supply chain dependency and creating compounding margin advantages.
Institutional Quality Standards
Multiple ISO certifications across both the healthcare services platform and the BioX Tech manufacturing division. Good Clinical Practices (GCP) compliance and a 10-year track record of safe, documented patient outcomes.
Proprietary Science
Peer-reviewed publications, patented formulations, and a Health Advisory Board of internationally recognized scientists and physicians — the scientific foundation of the Mayo Clinic of regenerative medicine.
Market Timing
The global regenerative medicine market is projected to exceed $100B by 2030. BioXcellerator is positioned at the intersection of clinical demand and manufacturing capability — with a decade of operational proof.
Experienced Operators. Proven in Healthcare.
The BioXcellerator leadership team combines deep clinical expertise, Fortune 100 healthcare executive experience, and a decade of operational track record in regenerative medicine.
Trusted by Elite Athletes Worldwide
BioXcellerator's regenerative protocols are trusted by professional athletes competing at the highest levels — from the UFC and NFL to the Olympics, Formula 1, and the PGA Tour.
Athletes from 14 major sports organizations have chosen BioXcellerator for performance recovery and regenerative care.
Medellín, Colombia — A Strategic Advantage
BioXcellerator's Medellín clinic provides a unique structural advantage: world-class medical infrastructure, a favorable regulatory environment for advanced cell therapies, significantly lower operational costs than U.S. or European markets, and access to a growing medical tourism market.
Trusted by Investors, Athletes & Leaders
BioXcellerator has earned the confidence of physicians, professional athletes, and respected leaders who have invested in the company's mission and long-term vision.
I've spent my career pushing the limits of what the human body can do. BioXcellerator is building the science that helps athletes like me recover faster, perform longer, and live better. When I looked at the clinical data and the team behind this platform, investing was a straightforward decision.
Tony Hawk is one of the most recognized athletes and entrepreneurs in the world, with a long track record of investing in health and performance technology.
Sports Medicine Physician · BioXcellerator Medical Advisor
“BioXcellerator represents the most clinically rigorous and commercially scalable regenerative medicine platform I have evaluated in over two decades of practice. The depth of their protocols, the quality of their manufacturing, and the strength of their leadership team gave me the confidence to invest.”
Dr. Palumbo brings 20+ years of sports medicine expertise and has personally evaluated BioXcellerator's clinical protocols.
Former Force Recon Marine · Author · Founder, Mighty Oaks Foundation
“I've seen what regenerative medicine can do for veterans and elite operators who've pushed their bodies to the limit. BioXcellerator's mission aligns with everything I believe about resilience, recovery, and giving people their lives back. I'm proud to be an investor.”
Chad Robichaux is a decorated veteran, bestselling author, and advocate for veteran wellness and resilience.
NFL Center · Dallas Cowboys · Super Bowl Contender
“At the professional level, recovery is everything. BioXcellerator's stem cell protocols have been a game-changer for how I approach my body and my career. When I saw the science and the results, investing was an easy decision.”
Tyler Biadasz is an NFL center who has experienced BioXcellerator's regenerative protocols firsthand as a patient and investor.
NFL Offensive Tackle · Miami Dolphins · 5× Pro Bowl Selection
“Longevity in the NFL requires more than talent — it requires the best recovery science available. BioXcellerator is setting the standard for what regenerative medicine can do for professional athletes. I believe in this company and what they're building.”
Terron Armstead is one of the NFL's premier offensive tackles, known for his commitment to elite performance and recovery.
Orthopedic Surgeon · HonorHealth · Non-Operative & Regenerative Medicine Specialist
“Regenerative medicine is reshaping how we approach orthopedic care. BioXcellerator's platform — the clinical rigor, the manufacturing infrastructure, the outcomes data — represents exactly the kind of science I want to stand behind as both a physician and an investor.”
Dr. Brimacombe is a board-eligible orthopedic physician specializing in non-operative treatment, hip, knee, shoulder, and hand conditions, arthritis, sports injuries, wound care, osteoporosis management, and injection-based therapies.
All testimonials reflect personal investment decisions. Past performance is not indicative of future results. For qualified investors only.
Tiered Access to Investment Materials
We provide the right information at the right time — from public overviews to full due diligence materials for qualified investors.
Stem Cell Secrets
By Eric Stoffers & Dr. Karolynn Halpert, MD
The definitive guide to regenerative medicine — written by the founders of BioXcellerator. Covering the science, the clinical evidence, 170+ treatable conditions, and how to evaluate any provider. Written for patients, physicians, and investors alike.
Request Access to Our Investor Data Room
Qualified investors can access our full suite of investment materials — from executive summaries to complete financial projections, legal structure, and product deep dives. Register to begin the qualification process.
All materials are confidential and subject to NDA. For qualified investors only.